Sekip Altunkan1, Nevzat Iliman, Erkan Altunkan. 1. Hypertension Division, Metropol Medical Center, Dişkapi Yildirim Beyazit Education and Research Hospital, Ankara, Turkey. saltunkan@superonline.com
Abstract
OBJECTIVE: Despite the widespread use of automated self-measurement monitors, there is limited published evidence on their accuracy and reliability on different patient groups. The objective of this study was to evaluate the accuracy and reliability of the Omron M6 (HEM-7001-E) upper-arm blood pressure (BP) device against mercury sphygmomanometer on elderly patients according to the criteria of the International Protocol. DESIGNS AND METHODS: Thirty-three patients above 65 years of age, who were classified based on the BP categories of the International Protocol, were recruited for the study. BP measurements at the upper arm with the Omron M6 were compared with the results obtained by two trained observers using a mercury sphygmomanometer. Nine sequential BP measurements were taken. During the validation study, 99 measurements were obtained from 33 patients for comparison. The first phase was carried out on 15 patients and if the device passed this phase, 18 more patients were selected. RESULTS: Mean discrepancies and standard deviations of the device sphygmomanometer were 1.4+/-5.3 mmHg for systolic BP (SBP) and -1.4+/-4.5 mmHg for diastolic BP (DBP) in the study group. The device passed phase 1 in 15 patients. In phase 2.1, from the total 99 comparisons, 76, 92, and 97 for SBP and 77, 94, and 99 for DBP were less than 5, 10, and 15 mmHg, respectively. The Omron M6 passed phases 2.1 and 2.2 in the elderly group of patients. CONCLUSION: The Omron M6 (HEM-7001-E) upper-arm BP monitor passed according to the International Protocol criteria and can be recommended for use in elderly patients.
OBJECTIVE: Despite the widespread use of automated self-measurement monitors, there is limited published evidence on their accuracy and reliability on different patient groups. The objective of this study was to evaluate the accuracy and reliability of the Omron M6 (HEM-7001-E) upper-arm blood pressure (BP) device against mercury sphygmomanometer on elderly patients according to the criteria of the International Protocol. DESIGNS AND METHODS: Thirty-three patients above 65 years of age, who were classified based on the BP categories of the International Protocol, were recruited for the study. BP measurements at the upper arm with the Omron M6 were compared with the results obtained by two trained observers using a mercury sphygmomanometer. Nine sequential BP measurements were taken. During the validation study, 99 measurements were obtained from 33 patients for comparison. The first phase was carried out on 15 patients and if the device passed this phase, 18 more patients were selected. RESULTS: Mean discrepancies and standard deviations of the device sphygmomanometer were 1.4+/-5.3 mmHg for systolic BP (SBP) and -1.4+/-4.5 mmHg for diastolic BP (DBP) in the study group. The device passed phase 1 in 15 patients. In phase 2.1, from the total 99 comparisons, 76, 92, and 97 for SBP and 77, 94, and 99 for DBP were less than 5, 10, and 15 mmHg, respectively. The Omron M6 passed phases 2.1 and 2.2 in the elderly group of patients. CONCLUSION: The Omron M6 (HEM-7001-E) upper-arm BP monitor passed according to the International Protocol criteria and can be recommended for use in elderly patients.
Authors: Daniel Sabater-Hernández; Pablo Sánchez-Villegas; José P García-Corpas; Pedro Amariles; José Sendra-Lillo; María J Faus Journal: Int J Clin Pharm Date: 2011-04-27
Authors: Daniel Sabater-Hernández; Alejandro De La Sierra; Pablo Sánchez-Villegas; Fidelina M Santana-Pérez; Luisa Merino-Barber; María J Faus Journal: J Clin Hypertens (Greenwich) Date: 2012-03-05 Impact factor: 3.738
Authors: Selma Gicevic; Emir Kremic; Teresa T Fung; Bernard Rosner; Edin Sabanovic; Walter C Willett Journal: Bull World Health Organ Date: 2019-03-25 Impact factor: 9.408
Authors: Victoria Mazoteras-Pardo; Ricardo Becerro-De-Bengoa-Vallejo; Marta Elena Losa-Iglesias; Daniel López-López; Patricia Palomo-López; David Rodríguez-Sanz; César Calvo-Lobo Journal: JMIR Mhealth Uhealth Date: 2018-10-25 Impact factor: 4.773
Authors: Deepti Gurdasani; Tommy Carstensen; Segun Fatumo; Guanjie Chen; Chris S Franklin; Javier Prado-Martinez; Heleen Bouman; Federico Abascal; Marc Haber; Ioanna Tachmazidou; Iain Mathieson; Kenneth Ekoru; Marianne K DeGorter; Rebecca N Nsubuga; Chris Finan; Eleanor Wheeler; Li Chen; David N Cooper; Stephan Schiffels; Yuan Chen; Graham R S Ritchie; Martin O Pollard; Mary D Fortune; Alex J Mentzer; Erik Garrison; Anders Bergström; Konstantinos Hatzikotoulas; Adebowale Adeyemo; Ayo Doumatey; Heather Elding; Louise V Wain; Georg Ehret; Paul L Auer; Charles L Kooperberg; Alexander P Reiner; Nora Franceschini; Dermot Maher; Stephen B Montgomery; Carl Kadie; Chris Widmer; Yali Xue; Janet Seeley; Gershim Asiki; Anatoli Kamali; Elizabeth H Young; Cristina Pomilla; Nicole Soranzo; Eleftheria Zeggini; Fraser Pirie; Andrew P Morris; David Heckerman; Chris Tyler-Smith; Ayesha A Motala; Charles Rotimi; Pontiano Kaleebu; Inês Barroso; Manj S Sandhu Journal: Cell Date: 2019-10-31 Impact factor: 41.582